SCHEMBL6419576

SCHEMBL6419576

CC(=O)S(=O)(=O)c1ccccn1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.48
PKM P14618 4/20 0.44
KDM4E B2RXH2 4/20 0.44
L3MBTL1 Q9Y468 2/20 0.42
CES2 O00748 1/20 0.42
CES1 P23141 1/20 0.42
KAT6A Q92794 1/20 0.41
LMNA P02545 3/20 0.41
NAPRT Q6XQN6 1/20 0.41
P4HTM Q9NXG6 1/20 0.41
ABCC9 O60706 1/20 0.40
ABCC8 Q09428 1/20 0.40
KCNJ11 Q14654 1/20 0.40
KCNJ8 Q15842 1/20 0.40
METAP2 P50579 1/20 0.40
NFE2L2 Q16236 2/20 0.40
MAPT P10636 1/20 0.39
TSHR P16473 2/20 0.39
CYP1A2 P05177 1/20 0.39
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18797621 0.83 PKM (0.47) ALDH1A1PKMKDM4EL3MBTL1CES2
SCHEMBL16549739 0.76 PKM (0.55) ALDH1A1PKMKDM4EL3MBTL1KAT6A
SCHEMBL18797618 0.76 POLB (0.48) ALDH1A1PKMKDM4EL3MBTL1CES2
SCHEMBL34548 0.74 KDM4E (0.50) ALDH1A1PKMKDM4EL3MBTL1CES2
SCHEMBL29622864 0.74 KDM4E (0.50) ALDH1A1PKMKDM4EL3MBTL1CES2
SCHEMBL29569774 0.74 KDM4E (0.50) ALDH1A1PKMKDM4EL3MBTL1LMNA
SCHEMBL323373 0.74 KDM4E (0.50) ALDH1A1PKMKDM4EL3MBTL1LMNA
SCHEMBL29908261 0.74 KDM4E (0.50) ALDH1A1PKMKDM4EL3MBTL1LMNA
SCHEMBL5238140 0.74 KDM4E (0.50) PKMKDM4EL3MBTL1CES2CES1
SCHEMBL1673906 0.73 KDM4E (0.64) PKMKDM4EL3MBTL1CES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050287594-A1 Activity-based probes having specificity to the active form of enzymes and receptors; screening for desired biological activities or target proteins SCRIPPS RESEARCH INSTITUTE, THE 2005-12-29 US disclosed
US-6872574-B2 Generating and screening compound libraries that are used for the identification of lead molecules, and for the parallel identification of their biological targets THE SCRIPPS RESEARCH INSTITUTE (US) 2005-03-29 US disclosed
EP-1275006-A2 PROTEOMIC ANALYSIS USING ACTIVITY-BASED PROBE LIBRARIES The Scripps Research Institute (US) 2003-01-15 EP disclosed
US-20020182652-A1 Proteomic analysis NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2002-12-05 US disclosed
US-20020064799-A1 Proteomic analysis THE SCRIPPS RESEARCH INSTITUTE OF AN ASSIGNMENT 2002-05-30 US disclosed
US-20020045194-A1 Proteomic analysis NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-04-18 US disclosed
US-20020040275-A1 Proteomic analysis THE SCRIPPS RESEARCH INSTITUTE 2002-04-04 US disclosed
WO-2001077684-A2 PROTEOMIC ANALYSIS USING ACTIVITY-BASED PROBE LIBRARIES THE SCRIPPS RESEARCH INSTITUTE (US) 2001-10-18 WO disclosed
WO-2001077668-A2 PROTEOMIC ANALYSIS USING ACTIVE-SITE DIRECTED PROBES THE SCRIPPS RESEARCH INSTITUTE (US) 2001-10-18 WO disclosed